OpenAlex
PricingAboutJobs
Log inGet started
Work

Enzyme therapy for Fabry disease: Neutralizing antibodies toward agalsidase alpha and beta

HTML

Year: 2004
Type: article
Study design: Observational Study
Source: Kidney International
DOI: 10.1111/j.1523-1755.2004.00924.x
Authors: Gabor E. Linthorst, Carla E.M. Hollak, Wilma E. Donker-Koopman, Anneke Strijland, Johannes M.F.G. Aerts
Institutions: Amsterdam UMC Location University of Amsterdam, University of Amsterdam
Language: English

Topic: Lysosomal Storage Disorders Research
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Keywords: Fabry disease, enzyme replacement therapy, alpha-galactosidase A, agalsidase alpha, agalsidase beta, neutralizing antibodies, globotriaosylceramide, lysosomal storage disease, cross-reactivity, enzyme-antibody complex, immunogenicity
SDG: Good health and well-being

Open Access status: bronze

Funder: Sanofi Genzyme
OpenAlex ID: W2000846576
FWCI: 6.791
Cites: 20
Cited by: 302
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security